Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02573545

Acronym

IFE

Enrollment

148

Registered

2015-10-09

Start date

2013-01-31

Completion date

2017-10-31

Last updated

2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Biopsy

Keywords

liver

Brief summary

To demonstrate that the use of Standard @IFE and Planning@IFE features of the IFE software, compared to the current method, when planning and inserting the needle under MRI monitoring in the context of liver biopsies enable: * a facilitation of the planning stages of the procedure (route path, marking of the entry point and alignment of the MRI cutaways on the planned path), resulting in a reduction in the duration of the planning stages, * a facilitation of the real-time modification of MRI cutaways during the procedure, resulting in a reduction of the duration of the procedure

Interventions

DEVICEPlanning@IFE and Standard@IFE Software

DEVICEMR Syngo (Numaris/4) software

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient is at least 18 years old * Affiliated to a social security scheme * Informed consent * Patient with an indication of liver biopsy eligible for a biopsy under interventional MRI

Exclusion criteria

* Patient with a contraindication for MRI exam * Patient with a contraindication for performing a biopsy * Pregnancy * Exclusion period * Patient unable to receive and understand information about the study * Patients under guardianship * Patients under judicial protection

Design outcomes

Primary

Measure	Time frame
Total duration of the intervention (planning and implementation)	up to 2 weeks

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026